nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—ABCC2—esophageal cancer	0.383	0.731	CbGaD
Carbamazepine—ABCB1—esophageal cancer	0.141	0.269	CbGaD
Carbamazepine—ABCC2—Carboplatin—esophageal cancer	0.0618	0.234	CbGbCtD
Carbamazepine—ABCC2—Cisplatin—esophageal cancer	0.0528	0.2	CbGbCtD
Carbamazepine—CYP2C9—Capecitabine—esophageal cancer	0.0352	0.134	CbGbCtD
Carbamazepine—ABCC2—Methotrexate—esophageal cancer	0.0343	0.13	CbGbCtD
Carbamazepine—CYP2B6—Cisplatin—esophageal cancer	0.0336	0.127	CbGbCtD
Carbamazepine—CYP2C9—Cisplatin—esophageal cancer	0.0177	0.0672	CbGbCtD
Carbamazepine—ABCB1—Cisplatin—esophageal cancer	0.0172	0.0653	CbGbCtD
Carbamazepine—ABCB1—Methotrexate—esophageal cancer	0.0112	0.0424	CbGbCtD
Carbamazepine—Nepafenac—PTGS1—esophageal cancer	0.00054	0.125	CrCbGaD
Carbamazepine—Magnesium salicylate—PTGS1—esophageal cancer	0.000528	0.122	CrCbGaD
Carbamazepine—Oxaprozin—PTGS1—esophageal cancer	0.000449	0.104	CrCbGaD
Carbamazepine—Salsalate—PTGS1—esophageal cancer	0.000449	0.104	CrCbGaD
Carbamazepine—Nepafenac—PTGS2—esophageal cancer	0.000309	0.0715	CrCbGaD
Carbamazepine—Magnesium salicylate—PTGS2—esophageal cancer	0.000302	0.0698	CrCbGaD
Carbamazepine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.0003	0.00288	CcSEcCtD
Carbamazepine—Aplastic anaemia—Methotrexate—esophageal cancer	0.000292	0.00281	CcSEcCtD
Carbamazepine—Bradycardia—Cisplatin—esophageal cancer	0.00029	0.00279	CcSEcCtD
Carbamazepine—Irritability—Capecitabine—esophageal cancer	0.00029	0.00278	CcSEcCtD
Carbamazepine—Cardiac arrest—Capecitabine—esophageal cancer	0.000289	0.00277	CcSEcCtD
Carbamazepine—Urinary retention—Capecitabine—esophageal cancer	0.000289	0.00277	CcSEcCtD
Carbamazepine—Ataxia—Capecitabine—esophageal cancer	0.000286	0.00274	CcSEcCtD
Carbamazepine—Coma—Methotrexate—esophageal cancer	0.000285	0.00273	CcSEcCtD
Carbamazepine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000281	0.0027	CcSEcCtD
Carbamazepine—Liver function test abnormal—Capecitabine—esophageal cancer	0.00028	0.00269	CcSEcCtD
Carbamazepine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00028	0.00269	CcSEcCtD
Carbamazepine—Urethral disorder—Cisplatin—esophageal cancer	0.000279	0.00268	CcSEcCtD
Carbamazepine—Gynaecomastia—Methotrexate—esophageal cancer	0.000279	0.00268	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000277	0.00266	CcSEcCtD
Carbamazepine—Pulmonary oedema—Methotrexate—esophageal cancer	0.000277	0.00266	CcSEcCtD
Carbamazepine—Hypokalaemia—Capecitabine—esophageal cancer	0.000276	0.00265	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000273	0.00263	CcSEcCtD
Carbamazepine—Phenytoin—ABCC2—esophageal cancer	0.000272	0.063	CrCbGaD
Carbamazepine—Muscular weakness—Capecitabine—esophageal cancer	0.000268	0.00257	CcSEcCtD
Carbamazepine—Eye disorder—Cisplatin—esophageal cancer	0.000266	0.00256	CcSEcCtD
Carbamazepine—Tinnitus—Cisplatin—esophageal cancer	0.000266	0.00255	CcSEcCtD
Carbamazepine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000265	0.00254	CcSEcCtD
Carbamazepine—Flushing—Cisplatin—esophageal cancer	0.000264	0.00254	CcSEcCtD
Carbamazepine—Cardiac disorder—Cisplatin—esophageal cancer	0.000264	0.00254	CcSEcCtD
Carbamazepine—Dysphagia—Capecitabine—esophageal cancer	0.000262	0.00252	CcSEcCtD
Carbamazepine—Thrombophlebitis—Methotrexate—esophageal cancer	0.000261	0.00251	CcSEcCtD
Carbamazepine—Photosensitivity—Methotrexate—esophageal cancer	0.000257	0.00247	CcSEcCtD
Carbamazepine—Polyuria—Methotrexate—esophageal cancer	0.000257	0.00247	CcSEcCtD
Carbamazepine—Immune system disorder—Cisplatin—esophageal cancer	0.000257	0.00247	CcSEcCtD
Carbamazepine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000257	0.00247	CcSEcCtD
Carbamazepine—Salsalate—PTGS2—esophageal cancer	0.000257	0.0594	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—esophageal cancer	0.000257	0.0594	CrCbGaD
Carbamazepine—Sweating increased—Capecitabine—esophageal cancer	0.000256	0.00246	CcSEcCtD
Carbamazepine—Arrhythmia—Cisplatin—esophageal cancer	0.000255	0.00244	CcSEcCtD
Carbamazepine—Bronchitis—Capecitabine—esophageal cancer	0.000252	0.00242	CcSEcCtD
Carbamazepine—Alopecia—Cisplatin—esophageal cancer	0.000252	0.00242	CcSEcCtD
Carbamazepine—Abdominal discomfort—Capecitabine—esophageal cancer	0.000252	0.00242	CcSEcCtD
Carbamazepine—Hepatic failure—Methotrexate—esophageal cancer	0.000252	0.00242	CcSEcCtD
Carbamazepine—Pancytopenia—Capecitabine—esophageal cancer	0.000249	0.00239	CcSEcCtD
Carbamazepine—Malnutrition—Cisplatin—esophageal cancer	0.000248	0.00238	CcSEcCtD
Carbamazepine—Erythema—Cisplatin—esophageal cancer	0.000248	0.00238	CcSEcCtD
Carbamazepine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00024	0.0023	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00024	0.0023	CcSEcCtD
Carbamazepine—Weight increased—Capecitabine—esophageal cancer	0.000239	0.00229	CcSEcCtD
Carbamazepine—Muscle spasms—Cisplatin—esophageal cancer	0.000239	0.00229	CcSEcCtD
Carbamazepine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000237	0.00227	CcSEcCtD
Carbamazepine—Pneumonia—Capecitabine—esophageal cancer	0.000235	0.00226	CcSEcCtD
Carbamazepine—Infestation NOS—Capecitabine—esophageal cancer	0.000234	0.00225	CcSEcCtD
Carbamazepine—Infestation—Capecitabine—esophageal cancer	0.000234	0.00225	CcSEcCtD
Carbamazepine—Vision blurred—Cisplatin—esophageal cancer	0.000234	0.00225	CcSEcCtD
Carbamazepine—Depression—Capecitabine—esophageal cancer	0.000233	0.00224	CcSEcCtD
Carbamazepine—Tremor—Cisplatin—esophageal cancer	0.000232	0.00223	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000232	0.00223	CcSEcCtD
Carbamazepine—Lethargy—Methotrexate—esophageal cancer	0.000231	0.00222	CcSEcCtD
Carbamazepine—Renal failure—Capecitabine—esophageal cancer	0.00023	0.00221	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000229	0.0022	CcSEcCtD
Carbamazepine—Anaemia—Cisplatin—esophageal cancer	0.000229	0.0022	CcSEcCtD
Carbamazepine—Stomatitis—Capecitabine—esophageal cancer	0.000228	0.00219	CcSEcCtD
Carbamazepine—Jaundice—Capecitabine—esophageal cancer	0.000228	0.00219	CcSEcCtD
Carbamazepine—Urinary tract infection—Capecitabine—esophageal cancer	0.000227	0.00218	CcSEcCtD
Carbamazepine—Conjunctivitis—Capecitabine—esophageal cancer	0.000227	0.00218	CcSEcCtD
Carbamazepine—Osteoarthritis—Methotrexate—esophageal cancer	0.000226	0.00217	CcSEcCtD
Carbamazepine—Haematuria—Capecitabine—esophageal cancer	0.000223	0.00214	CcSEcCtD
Carbamazepine—Leukopenia—Cisplatin—esophageal cancer	0.000222	0.00213	CcSEcCtD
Carbamazepine—Protriptyline—ABCB1—esophageal cancer	0.000222	0.0513	CrCbGaD
Carbamazepine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000221	0.00213	CcSEcCtD
Carbamazepine—Agranulocytosis—Capecitabine—esophageal cancer	0.000218	0.0021	CcSEcCtD
Carbamazepine—Irritability—Methotrexate—esophageal cancer	0.000216	0.00207	CcSEcCtD
Carbamazepine—Convulsion—Cisplatin—esophageal cancer	0.000215	0.00206	CcSEcCtD
Carbamazepine—Bradycardia—Capecitabine—esophageal cancer	0.000214	0.00205	CcSEcCtD
Carbamazepine—Ataxia—Methotrexate—esophageal cancer	0.000213	0.00204	CcSEcCtD
Carbamazepine—Myalgia—Cisplatin—esophageal cancer	0.000211	0.00203	CcSEcCtD
Carbamazepine—Rhinitis—Capecitabine—esophageal cancer	0.000211	0.00202	CcSEcCtD
Carbamazepine—Anxiety—Cisplatin—esophageal cancer	0.00021	0.00202	CcSEcCtD
Carbamazepine—Hepatitis—Capecitabine—esophageal cancer	0.00021	0.00202	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00021	0.00201	CcSEcCtD
Carbamazepine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000209	0.002	CcSEcCtD
Carbamazepine—Pharyngitis—Capecitabine—esophageal cancer	0.000208	0.002	CcSEcCtD
Carbamazepine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000207	0.00199	CcSEcCtD
Carbamazepine—Oedema peripheral—Capecitabine—esophageal cancer	0.000207	0.00199	CcSEcCtD
Carbamazepine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000206	0.00198	CcSEcCtD
Carbamazepine—Urethral disorder—Capecitabine—esophageal cancer	0.000206	0.00198	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000204	0.00195	CcSEcCtD
Carbamazepine—Oedema—Cisplatin—esophageal cancer	0.000202	0.00194	CcSEcCtD
Carbamazepine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000202	0.00194	CcSEcCtD
Carbamazepine—Infection—Cisplatin—esophageal cancer	0.000201	0.00193	CcSEcCtD
Carbamazepine—Erythema multiforme—Capecitabine—esophageal cancer	0.000199	0.00191	CcSEcCtD
Carbamazepine—Nervous system disorder—Cisplatin—esophageal cancer	0.000199	0.00191	CcSEcCtD
Carbamazepine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000198	0.0019	CcSEcCtD
Carbamazepine—Tachycardia—Cisplatin—esophageal cancer	0.000198	0.0019	CcSEcCtD
Carbamazepine—Skin disorder—Cisplatin—esophageal cancer	0.000197	0.00189	CcSEcCtD
Carbamazepine—Eye disorder—Capecitabine—esophageal cancer	0.000196	0.00189	CcSEcCtD
Carbamazepine—Tinnitus—Capecitabine—esophageal cancer	0.000196	0.00188	CcSEcCtD
Carbamazepine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000196	0.00188	CcSEcCtD
Carbamazepine—Cardiac disorder—Capecitabine—esophageal cancer	0.000195	0.00187	CcSEcCtD
Carbamazepine—Flushing—Capecitabine—esophageal cancer	0.000195	0.00187	CcSEcCtD
Carbamazepine—Eosinophilia—Methotrexate—esophageal cancer	0.000193	0.00186	CcSEcCtD
Carbamazepine—Anorexia—Cisplatin—esophageal cancer	0.000193	0.00185	CcSEcCtD
Carbamazepine—Pancreatitis—Methotrexate—esophageal cancer	0.000192	0.00184	CcSEcCtD
Carbamazepine—Angiopathy—Capecitabine—esophageal cancer	0.000191	0.00183	CcSEcCtD
Carbamazepine—Immune system disorder—Capecitabine—esophageal cancer	0.00019	0.00182	CcSEcCtD
Carbamazepine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000189	0.00182	CcSEcCtD
Carbamazepine—Hypotension—Cisplatin—esophageal cancer	0.000189	0.00182	CcSEcCtD
Carbamazepine—Chills—Capecitabine—esophageal cancer	0.000188	0.00181	CcSEcCtD
Carbamazepine—Desipramine—CYP2A6—esophageal cancer	0.000188	0.0434	CrCbGaD
Carbamazepine—Arrhythmia—Capecitabine—esophageal cancer	0.000188	0.0018	CcSEcCtD
Carbamazepine—Abdominal discomfort—Methotrexate—esophageal cancer	0.000187	0.0018	CcSEcCtD
Carbamazepine—Alopecia—Capecitabine—esophageal cancer	0.000186	0.00178	CcSEcCtD
Carbamazepine—Pancytopenia—Methotrexate—esophageal cancer	0.000186	0.00178	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000184	0.00177	CcSEcCtD
Carbamazepine—Mental disorder—Capecitabine—esophageal cancer	0.000184	0.00177	CcSEcCtD
Carbamazepine—Erythema—Capecitabine—esophageal cancer	0.000183	0.00176	CcSEcCtD
Carbamazepine—Malnutrition—Capecitabine—esophageal cancer	0.000183	0.00176	CcSEcCtD
Carbamazepine—Paraesthesia—Cisplatin—esophageal cancer	0.000182	0.00175	CcSEcCtD
Carbamazepine—Dyspnoea—Cisplatin—esophageal cancer	0.000181	0.00173	CcSEcCtD
Carbamazepine—Erectile dysfunction—Methotrexate—esophageal cancer	0.00018	0.00173	CcSEcCtD
Carbamazepine—Dysgeusia—Capecitabine—esophageal cancer	0.000179	0.00172	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000178	0.00171	CcSEcCtD
Carbamazepine—Back pain—Capecitabine—esophageal cancer	0.000177	0.0017	CcSEcCtD
Carbamazepine—Decreased appetite—Cisplatin—esophageal cancer	0.000176	0.00169	CcSEcCtD
Carbamazepine—Muscle spasms—Capecitabine—esophageal cancer	0.000176	0.00169	CcSEcCtD
Carbamazepine—Pneumonia—Methotrexate—esophageal cancer	0.000175	0.00168	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000175	0.00168	CcSEcCtD
Carbamazepine—Infestation NOS—Methotrexate—esophageal cancer	0.000174	0.00167	CcSEcCtD
Carbamazepine—Infestation—Methotrexate—esophageal cancer	0.000174	0.00167	CcSEcCtD
Carbamazepine—Drowsiness—Methotrexate—esophageal cancer	0.000174	0.00167	CcSEcCtD
Carbamazepine—Depression—Methotrexate—esophageal cancer	0.000174	0.00167	CcSEcCtD
Carbamazepine—Pain—Cisplatin—esophageal cancer	0.000173	0.00166	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000173	0.00166	CcSEcCtD
Carbamazepine—Vision blurred—Capecitabine—esophageal cancer	0.000172	0.00165	CcSEcCtD
Carbamazepine—Tremor—Capecitabine—esophageal cancer	0.000171	0.00165	CcSEcCtD
Carbamazepine—Renal failure—Methotrexate—esophageal cancer	0.000171	0.00164	CcSEcCtD
Carbamazepine—Stomatitis—Methotrexate—esophageal cancer	0.00017	0.00163	CcSEcCtD
Carbamazepine—Conjunctivitis—Methotrexate—esophageal cancer	0.000169	0.00163	CcSEcCtD
Carbamazepine—Anaemia—Capecitabine—esophageal cancer	0.000169	0.00162	CcSEcCtD
Carbamazepine—Feeling abnormal—Cisplatin—esophageal cancer	0.000167	0.0016	CcSEcCtD
Carbamazepine—Haematuria—Methotrexate—esophageal cancer	0.000166	0.0016	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000165	0.00158	CcSEcCtD
Carbamazepine—Vertigo—Capecitabine—esophageal cancer	0.000164	0.00158	CcSEcCtD
Carbamazepine—Epinastine—ABCB1—esophageal cancer	0.000164	0.038	CrCbGaD
Carbamazepine—Syncope—Capecitabine—esophageal cancer	0.000164	0.00157	CcSEcCtD
Carbamazepine—Leukopenia—Capecitabine—esophageal cancer	0.000164	0.00157	CcSEcCtD
Carbamazepine—Agranulocytosis—Methotrexate—esophageal cancer	0.000163	0.00156	CcSEcCtD
Carbamazepine—Loss of consciousness—Capecitabine—esophageal cancer	0.000161	0.00154	CcSEcCtD
Carbamazepine—Body temperature increased—Cisplatin—esophageal cancer	0.00016	0.00154	CcSEcCtD
Carbamazepine—Hypertension—Capecitabine—esophageal cancer	0.000158	0.00152	CcSEcCtD
Carbamazepine—Hepatitis—Methotrexate—esophageal cancer	0.000156	0.0015	CcSEcCtD
Carbamazepine—Arthralgia—Capecitabine—esophageal cancer	0.000156	0.0015	CcSEcCtD
Carbamazepine—Myalgia—Capecitabine—esophageal cancer	0.000156	0.0015	CcSEcCtD
Carbamazepine—Chest pain—Capecitabine—esophageal cancer	0.000156	0.0015	CcSEcCtD
Carbamazepine—Pharyngitis—Methotrexate—esophageal cancer	0.000155	0.00149	CcSEcCtD
Carbamazepine—Anxiety—Capecitabine—esophageal cancer	0.000155	0.00149	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000155	0.00148	CcSEcCtD
Carbamazepine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000154	0.00148	CcSEcCtD
Carbamazepine—Urethral disorder—Methotrexate—esophageal cancer	0.000153	0.00147	CcSEcCtD
Carbamazepine—Dry mouth—Capecitabine—esophageal cancer	0.000152	0.00146	CcSEcCtD
Carbamazepine—Confusional state—Capecitabine—esophageal cancer	0.00015	0.00145	CcSEcCtD
Carbamazepine—Oedema—Capecitabine—esophageal cancer	0.000149	0.00143	CcSEcCtD
Carbamazepine—Hypersensitivity—Cisplatin—esophageal cancer	0.000149	0.00143	CcSEcCtD
Carbamazepine—Infection—Capecitabine—esophageal cancer	0.000148	0.00142	CcSEcCtD
Carbamazepine—Erythema multiforme—Methotrexate—esophageal cancer	0.000148	0.00142	CcSEcCtD
Carbamazepine—Shock—Capecitabine—esophageal cancer	0.000147	0.00141	CcSEcCtD
Carbamazepine—Nervous system disorder—Capecitabine—esophageal cancer	0.000146	0.00141	CcSEcCtD
Carbamazepine—Eye disorder—Methotrexate—esophageal cancer	0.000146	0.0014	CcSEcCtD
Carbamazepine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000146	0.0014	CcSEcCtD
Carbamazepine—Tinnitus—Methotrexate—esophageal cancer	0.000146	0.0014	CcSEcCtD
Carbamazepine—Tachycardia—Capecitabine—esophageal cancer	0.000146	0.0014	CcSEcCtD
Carbamazepine—Asthenia—Cisplatin—esophageal cancer	0.000145	0.00139	CcSEcCtD
Carbamazepine—Cardiac disorder—Methotrexate—esophageal cancer	0.000145	0.00139	CcSEcCtD
Carbamazepine—Skin disorder—Capecitabine—esophageal cancer	0.000145	0.00139	CcSEcCtD
Carbamazepine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000144	0.00139	CcSEcCtD
Carbamazepine—Anorexia—Capecitabine—esophageal cancer	0.000142	0.00137	CcSEcCtD
Carbamazepine—Angiopathy—Methotrexate—esophageal cancer	0.000142	0.00136	CcSEcCtD
Carbamazepine—Immune system disorder—Methotrexate—esophageal cancer	0.000141	0.00136	CcSEcCtD
Carbamazepine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000141	0.00135	CcSEcCtD
Carbamazepine—Chills—Methotrexate—esophageal cancer	0.00014	0.00135	CcSEcCtD
Carbamazepine—Hypotension—Capecitabine—esophageal cancer	0.000139	0.00134	CcSEcCtD
Carbamazepine—Diarrhoea—Cisplatin—esophageal cancer	0.000139	0.00133	CcSEcCtD
Carbamazepine—Alopecia—Methotrexate—esophageal cancer	0.000138	0.00133	CcSEcCtD
Carbamazepine—Mental disorder—Methotrexate—esophageal cancer	0.000137	0.00132	CcSEcCtD
Carbamazepine—Erythema—Methotrexate—esophageal cancer	0.000136	0.00131	CcSEcCtD
Carbamazepine—Malnutrition—Methotrexate—esophageal cancer	0.000136	0.00131	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000136	0.00131	CcSEcCtD
Carbamazepine—Insomnia—Capecitabine—esophageal cancer	0.000135	0.0013	CcSEcCtD
Carbamazepine—Paraesthesia—Capecitabine—esophageal cancer	0.000134	0.00129	CcSEcCtD
Carbamazepine—Dysgeusia—Methotrexate—esophageal cancer	0.000133	0.00128	CcSEcCtD
Carbamazepine—Dyspnoea—Capecitabine—esophageal cancer	0.000133	0.00128	CcSEcCtD
Carbamazepine—Back pain—Methotrexate—esophageal cancer	0.000132	0.00126	CcSEcCtD
Carbamazepine—Dyspepsia—Capecitabine—esophageal cancer	0.000131	0.00126	CcSEcCtD
Carbamazepine—Decreased appetite—Capecitabine—esophageal cancer	0.00013	0.00125	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000129	0.00124	CcSEcCtD
Carbamazepine—Vomiting—Cisplatin—esophageal cancer	0.000129	0.00124	CcSEcCtD
Carbamazepine—Fatigue—Capecitabine—esophageal cancer	0.000129	0.00124	CcSEcCtD
Carbamazepine—Vision blurred—Methotrexate—esophageal cancer	0.000128	0.00123	CcSEcCtD
Carbamazepine—Rash—Cisplatin—esophageal cancer	0.000128	0.00123	CcSEcCtD
Carbamazepine—Pain—Capecitabine—esophageal cancer	0.000128	0.00123	CcSEcCtD
Carbamazepine—Constipation—Capecitabine—esophageal cancer	0.000128	0.00123	CcSEcCtD
Carbamazepine—Dermatitis—Cisplatin—esophageal cancer	0.000128	0.00122	CcSEcCtD
Carbamazepine—Anaemia—Methotrexate—esophageal cancer	0.000126	0.00121	CcSEcCtD
Carbamazepine—Feeling abnormal—Capecitabine—esophageal cancer	0.000123	0.00118	CcSEcCtD
Carbamazepine—Vertigo—Methotrexate—esophageal cancer	0.000122	0.00117	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000122	0.00117	CcSEcCtD
Carbamazepine—Leukopenia—Methotrexate—esophageal cancer	0.000122	0.00117	CcSEcCtD
Carbamazepine—Nausea—Cisplatin—esophageal cancer	0.00012	0.00115	CcSEcCtD
Carbamazepine—Urticaria—Capecitabine—esophageal cancer	0.000119	0.00114	CcSEcCtD
Carbamazepine—Body temperature increased—Capecitabine—esophageal cancer	0.000118	0.00113	CcSEcCtD
Carbamazepine—Abdominal pain—Capecitabine—esophageal cancer	0.000118	0.00113	CcSEcCtD
Carbamazepine—Convulsion—Methotrexate—esophageal cancer	0.000118	0.00113	CcSEcCtD
Carbamazepine—Arthralgia—Methotrexate—esophageal cancer	0.000116	0.00111	CcSEcCtD
Carbamazepine—Myalgia—Methotrexate—esophageal cancer	0.000116	0.00111	CcSEcCtD
Carbamazepine—Chest pain—Methotrexate—esophageal cancer	0.000116	0.00111	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000115	0.00111	CcSEcCtD
Carbamazepine—Confusional state—Methotrexate—esophageal cancer	0.000112	0.00108	CcSEcCtD
Carbamazepine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000111	0.00107	CcSEcCtD
Carbamazepine—Infection—Methotrexate—esophageal cancer	0.00011	0.00106	CcSEcCtD
Carbamazepine—Hypersensitivity—Capecitabine—esophageal cancer	0.00011	0.00106	CcSEcCtD
Carbamazepine—Nervous system disorder—Methotrexate—esophageal cancer	0.000109	0.00105	CcSEcCtD
Carbamazepine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000109	0.00104	CcSEcCtD
Carbamazepine—Skin disorder—Methotrexate—esophageal cancer	0.000108	0.00104	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000107	0.00103	CcSEcCtD
Carbamazepine—Asthenia—Capecitabine—esophageal cancer	0.000107	0.00103	CcSEcCtD
Carbamazepine—Anorexia—Methotrexate—esophageal cancer	0.000106	0.00102	CcSEcCtD
Carbamazepine—Pruritus—Capecitabine—esophageal cancer	0.000106	0.00101	CcSEcCtD
Carbamazepine—Hypotension—Methotrexate—esophageal cancer	0.000104	0.000997	CcSEcCtD
Carbamazepine—Diarrhoea—Capecitabine—esophageal cancer	0.000102	0.000981	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000101	0.000972	CcSEcCtD
Carbamazepine—Insomnia—Methotrexate—esophageal cancer	0.0001	0.000965	CcSEcCtD
Carbamazepine—Phenytoin—ABCB1—esophageal cancer	0.0001	0.0232	CrCbGaD
Carbamazepine—Paraesthesia—Methotrexate—esophageal cancer	9.98e-05	0.000958	CcSEcCtD
Carbamazepine—Dyspnoea—Methotrexate—esophageal cancer	9.91e-05	0.000951	CcSEcCtD
Carbamazepine—Somnolence—Methotrexate—esophageal cancer	9.88e-05	0.000948	CcSEcCtD
Carbamazepine—Dizziness—Capecitabine—esophageal cancer	9.87e-05	0.000948	CcSEcCtD
Carbamazepine—Dyspepsia—Methotrexate—esophageal cancer	9.78e-05	0.000939	CcSEcCtD
Carbamazepine—Decreased appetite—Methotrexate—esophageal cancer	9.66e-05	0.000927	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Methotrexate—esophageal cancer	9.59e-05	0.000921	CcSEcCtD
Carbamazepine—Fatigue—Methotrexate—esophageal cancer	9.58e-05	0.00092	CcSEcCtD
Carbamazepine—Pain—Methotrexate—esophageal cancer	9.5e-05	0.000912	CcSEcCtD
Carbamazepine—Vomiting—Capecitabine—esophageal cancer	9.49e-05	0.000911	CcSEcCtD
Carbamazepine—Rash—Capecitabine—esophageal cancer	9.41e-05	0.000904	CcSEcCtD
Carbamazepine—Dermatitis—Capecitabine—esophageal cancer	9.4e-05	0.000903	CcSEcCtD
Carbamazepine—Headache—Capecitabine—esophageal cancer	9.35e-05	0.000898	CcSEcCtD
Carbamazepine—Feeling abnormal—Methotrexate—esophageal cancer	9.16e-05	0.000879	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methotrexate—esophageal cancer	9.09e-05	0.000872	CcSEcCtD
Carbamazepine—Nausea—Capecitabine—esophageal cancer	8.87e-05	0.000851	CcSEcCtD
Carbamazepine—Urticaria—Methotrexate—esophageal cancer	8.83e-05	0.000848	CcSEcCtD
Carbamazepine—Abdominal pain—Methotrexate—esophageal cancer	8.78e-05	0.000843	CcSEcCtD
Carbamazepine—Body temperature increased—Methotrexate—esophageal cancer	8.78e-05	0.000843	CcSEcCtD
Carbamazepine—Hypersensitivity—Methotrexate—esophageal cancer	8.19e-05	0.000786	CcSEcCtD
Carbamazepine—Trimipramine—ABCB1—esophageal cancer	8e-05	0.0185	CrCbGaD
Carbamazepine—Asthenia—Methotrexate—esophageal cancer	7.97e-05	0.000765	CcSEcCtD
Carbamazepine—Pruritus—Methotrexate—esophageal cancer	7.86e-05	0.000755	CcSEcCtD
Carbamazepine—Promethazine—ABCB1—esophageal cancer	7.7e-05	0.0178	CrCbGaD
Carbamazepine—Diarrhoea—Methotrexate—esophageal cancer	7.6e-05	0.00073	CcSEcCtD
Carbamazepine—Dizziness—Methotrexate—esophageal cancer	7.35e-05	0.000706	CcSEcCtD
Carbamazepine—Vomiting—Methotrexate—esophageal cancer	7.06e-05	0.000678	CcSEcCtD
Carbamazepine—Rash—Methotrexate—esophageal cancer	7.01e-05	0.000673	CcSEcCtD
Carbamazepine—Dermatitis—Methotrexate—esophageal cancer	7e-05	0.000672	CcSEcCtD
Carbamazepine—Desipramine—ABCB1—esophageal cancer	6.99e-05	0.0162	CrCbGaD
Carbamazepine—Headache—Methotrexate—esophageal cancer	6.96e-05	0.000668	CcSEcCtD
Carbamazepine—Nausea—Methotrexate—esophageal cancer	6.6e-05	0.000634	CcSEcCtD
Carbamazepine—Imipramine—ABCB1—esophageal cancer	5.93e-05	0.0137	CrCbGaD
Carbamazepine—CYP2C8—Metabolism—TYMP—esophageal cancer	1.54e-05	0.000148	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GAPDH—esophageal cancer	1.52e-05	0.000146	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.51e-05	0.000145	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MYC—esophageal cancer	1.51e-05	0.000145	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CRABP1—esophageal cancer	1.5e-05	0.000144	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CA1—esophageal cancer	1.5e-05	0.000144	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SLC10A2—esophageal cancer	1.5e-05	0.000144	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.5e-05	0.000144	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ADH7—esophageal cancer	1.5e-05	0.000144	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.5e-05	0.000144	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GAPDH—esophageal cancer	1.48e-05	0.000142	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.48e-05	0.000142	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—EGFR—esophageal cancer	1.48e-05	0.000142	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CRABP1—esophageal cancer	1.47e-05	0.000141	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.46e-05	0.00014	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.44e-05	0.000138	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GNG7—esophageal cancer	1.43e-05	0.000137	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ADH1B—esophageal cancer	1.4e-05	0.000135	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GNG7—esophageal cancer	1.4e-05	0.000134	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.39e-05	0.000134	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—TPI1—esophageal cancer	1.39e-05	0.000134	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CA2—esophageal cancer	1.37e-05	0.000132	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TYMP—esophageal cancer	1.37e-05	0.000132	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP1B1—esophageal cancer	1.37e-05	0.000132	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.37e-05	0.000132	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.36e-05	0.000131	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.36e-05	0.000131	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.34e-05	0.000129	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TYMP—esophageal cancer	1.34e-05	0.000129	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ALDH2—esophageal cancer	1.34e-05	0.000129	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.34e-05	0.000128	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.34e-05	0.000128	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.32e-05	0.000126	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.31e-05	0.000126	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.31e-05	0.000126	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.31e-05	0.000125	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.3e-05	0.000125	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CYP19A1—esophageal cancer	1.29e-05	0.000124	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.29e-05	0.000124	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.29e-05	0.000123	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PIK3CA—esophageal cancer	1.28e-05	0.000123	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.28e-05	0.000123	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ADH7—esophageal cancer	1.28e-05	0.000123	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.28e-05	0.000122	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.27e-05	0.000122	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALOX15—esophageal cancer	1.27e-05	0.000122	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.26e-05	0.000121	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.26e-05	0.000121	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TYMP—esophageal cancer	1.25e-05	0.00012	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.25e-05	0.00012	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.24e-05	0.000119	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TPI1—esophageal cancer	1.24e-05	0.000119	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—esophageal cancer	1.24e-05	0.000119	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.23e-05	0.000118	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.22e-05	0.000117	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TPI1—esophageal cancer	1.21e-05	0.000116	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTO1—esophageal cancer	1.21e-05	0.000116	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GNG7—esophageal cancer	1.21e-05	0.000116	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ENO1—esophageal cancer	1.2e-05	0.000115	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.2e-05	0.000115	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.19e-05	0.000114	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.19e-05	0.000114	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—HMOX1—esophageal cancer	1.18e-05	0.000113	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PSME2—esophageal cancer	1.18e-05	0.000113	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PSME1—esophageal cancer	1.18e-05	0.000113	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS1—esophageal cancer	1.17e-05	0.000112	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ENO1—esophageal cancer	1.17e-05	0.000112	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALDOB—esophageal cancer	1.16e-05	0.000112	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.16e-05	0.000111	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CA1—esophageal cancer	1.16e-05	0.000111	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PSME1—esophageal cancer	1.15e-05	0.00011	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PSME2—esophageal cancer	1.15e-05	0.00011	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.15e-05	0.00011	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.14e-05	0.000109	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.14e-05	0.000109	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.13e-05	0.000109	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TPI1—esophageal cancer	1.13e-05	0.000109	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ABCB1—esophageal cancer	1.13e-05	0.000109	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.12e-05	0.000108	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GAPDH—esophageal cancer	1.12e-05	0.000107	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.12e-05	0.000107	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CRABP1—esophageal cancer	1.11e-05	0.000107	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—CREBBP—esophageal cancer	1.11e-05	0.000106	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.09e-05	0.000104	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GNG7—esophageal cancer	1.08e-05	0.000104	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.08e-05	0.000104	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.08e-05	0.000104	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TYMP—esophageal cancer	1.07e-05	0.000103	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.07e-05	0.000102	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.06e-05	0.000102	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CA2—esophageal cancer	1.06e-05	0.000102	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GNG7—esophageal cancer	1.06e-05	0.000101	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.05e-05	0.0001	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.04e-05	0.0001	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.04e-05	9.95e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.02e-05	9.76e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.02e-05	9.75e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.01e-05	9.73e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.01e-05	9.71e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ENO1—esophageal cancer	1.01e-05	9.71e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PSME1—esophageal cancer	9.97e-06	9.57e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PSME2—esophageal cancer	9.97e-06	9.57e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	9.93e-06	9.53e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—NOS3—esophageal cancer	9.91e-06	9.51e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALDH2—esophageal cancer	9.89e-06	9.49e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.86e-06	9.47e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ADH7—esophageal cancer	9.86e-06	9.47e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GNG7—esophageal cancer	9.86e-06	9.46e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TPI1—esophageal cancer	9.69e-06	9.3e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTO1—esophageal cancer	9.69e-06	9.3e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTT1—esophageal cancer	9.64e-06	9.25e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CYP19A1—esophageal cancer	9.56e-06	9.17e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	9.53e-06	9.15e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.49e-06	9.11e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTT1—esophageal cancer	9.41e-06	9.03e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	9.34e-06	8.96e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP2A6—esophageal cancer	9.3e-06	8.93e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALDOB—esophageal cancer	9.29e-06	8.91e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALDH2—esophageal cancer	9.24e-06	8.87e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTGS2—esophageal cancer	9.06e-06	8.7e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ENO1—esophageal cancer	9.03e-06	8.67e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS1—esophageal cancer	9.03e-06	8.67e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GAPDH—esophageal cancer	8.94e-06	8.58e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PSME2—esophageal cancer	8.9e-06	8.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PSME1—esophageal cancer	8.9e-06	8.54e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CRABP1—esophageal cancer	8.86e-06	8.5e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ENO1—esophageal cancer	8.82e-06	8.46e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS1—esophageal cancer	8.82e-06	8.46e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.81e-06	8.45e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTT1—esophageal cancer	8.79e-06	8.44e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—HMOX1—esophageal cancer	8.72e-06	8.37e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.71e-06	8.36e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	8.69e-06	8.34e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PSME2—esophageal cancer	8.69e-06	8.34e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PSME1—esophageal cancer	8.69e-06	8.34e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.65e-06	8.31e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.65e-06	8.3e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	8.6e-06	8.26e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—HMOX1—esophageal cancer	8.52e-06	8.18e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GNG7—esophageal cancer	8.43e-06	8.09e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ABCB1—esophageal cancer	8.37e-06	8.03e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TYMP—esophageal cancer	8.27e-06	7.93e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ENO1—esophageal cancer	8.24e-06	7.91e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS1—esophageal cancer	8.24e-06	7.91e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ABCB1—esophageal cancer	8.18e-06	7.85e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PSME1—esophageal cancer	8.12e-06	7.79e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PSME2—esophageal cancer	8.12e-06	7.79e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	8.09e-06	7.76e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	8.04e-06	7.72e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALDH2—esophageal cancer	7.9e-06	7.58e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.84e-06	7.52e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.77e-06	7.46e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	7.68e-06	7.37e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CREBBP—esophageal cancer	7.56e-06	7.26e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—EP300—esophageal cancer	7.54e-06	7.23e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTT1—esophageal cancer	7.51e-06	7.21e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP1B1—esophageal cancer	7.5e-06	7.19e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TPI1—esophageal cancer	7.48e-06	7.18e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.48e-06	7.18e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	7.42e-06	7.13e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.4e-06	7.1e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HMOX1—esophageal cancer	7.38e-06	7.09e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.24e-06	6.95e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	7.22e-06	6.93e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALDOB—esophageal cancer	7.17e-06	6.88e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.09e-06	6.8e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ABCB1—esophageal cancer	7.09e-06	6.8e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYP19A1—esophageal cancer	7.05e-06	6.76e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO1—esophageal cancer	7.04e-06	6.76e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS1—esophageal cancer	7.04e-06	6.76e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	7e-06	6.72e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PSME1—esophageal cancer	6.94e-06	6.66e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PSME2—esophageal cancer	6.94e-06	6.66e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.9e-06	6.62e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.84e-06	6.56e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NOS3—esophageal cancer	6.77e-06	6.5e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HMOX1—esophageal cancer	6.59e-06	6.32e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	6.58e-06	6.32e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GNG7—esophageal cancer	6.5e-06	6.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.46e-06	6.2e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HMOX1—esophageal cancer	6.43e-06	6.17e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ABCB1—esophageal cancer	6.32e-06	6.07e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTGS2—esophageal cancer	6.19e-06	5.94e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALDH2—esophageal cancer	6.09e-06	5.85e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.06e-06	5.81e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HMOX1—esophageal cancer	6.01e-06	5.77e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	5.98e-06	5.74e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.89e-06	5.66e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.8e-06	5.56e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.77e-06	5.54e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.73e-06	5.5e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	5.63e-06	5.4e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CREBBP—esophageal cancer	5.59e-06	5.37e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CA—esophageal cancer	5.58e-06	5.35e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CREBBP—esophageal cancer	5.47e-06	5.25e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.43e-06	5.21e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO1—esophageal cancer	5.43e-06	5.21e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.36e-06	5.14e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PSME2—esophageal cancer	5.35e-06	5.14e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PSME1—esophageal cancer	5.35e-06	5.14e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—EP300—esophageal cancer	5.15e-06	4.94e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HMOX1—esophageal cancer	5.13e-06	4.93e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.04e-06	4.83e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NOS3—esophageal cancer	5.01e-06	4.81e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCB1—esophageal cancer	4.93e-06	4.73e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NOS3—esophageal cancer	4.9e-06	4.7e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.78e-06	4.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CREBBP—esophageal cancer	4.74e-06	4.55e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.62e-06	4.43e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTGS2—esophageal cancer	4.58e-06	4.4e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTGS2—esophageal cancer	4.48e-06	4.3e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.36e-06	4.18e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.34e-06	4.17e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NOS3—esophageal cancer	4.24e-06	4.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CREBBP—esophageal cancer	4.23e-06	4.06e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CREBBP—esophageal cancer	4.13e-06	3.96e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.96e-06	3.8e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.88e-06	3.72e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.85e-06	3.7e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.81e-06	3.66e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—EP300—esophageal cancer	3.81e-06	3.66e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.8e-06	3.65e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NOS3—esophageal cancer	3.78e-06	3.63e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.73e-06	3.58e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—EP300—esophageal cancer	3.72e-06	3.57e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NOS3—esophageal cancer	3.69e-06	3.55e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTGS2—esophageal cancer	3.46e-06	3.32e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NOS3—esophageal cancer	3.45e-06	3.31e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTGS2—esophageal cancer	3.38e-06	3.24e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CREBBP—esophageal cancer	3.29e-06	3.16e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—EP300—esophageal cancer	3.23e-06	3.1e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.16e-06	3.03e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NOS3—esophageal cancer	2.95e-06	2.83e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—EP300—esophageal cancer	2.88e-06	2.76e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	2.82e-06	2.7e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—EP300—esophageal cancer	2.81e-06	2.7e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.75e-06	2.64e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.7e-06	2.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—EP300—esophageal cancer	2.63e-06	2.52e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.54e-06	2.44e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.39e-06	2.29e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NOS3—esophageal cancer	2.28e-06	2.18e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—EP300—esophageal cancer	2.24e-06	2.15e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.13e-06	2.04e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.08e-06	2e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.08e-06	2e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.94e-06	1.86e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—EP300—esophageal cancer	1.73e-06	1.66e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.66e-06	1.59e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.28e-06	1.23e-05	CbGpPWpGaD
